Cerecin Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.74M

  • Investors
  • 13

Cerecin General Information

Description

Developer of therapeutics technology designed to treat memory impairment and other neurodegenerative diseases. The company offers lipid science to explore the potential therapeutic benefits of medium-chain triglycerides, which are designed to induce ketosis and improve mitochondrial metabolism, and develops novel evidence-based alternatives that help people, pharmaceuticals, medical foods, diagnostics, medical devices, and e-health products, enabling clinicians to have access to brain health-focused products and therapies to treat diseases of the brain.

Contact Information

Website
www.cerecin.com
Formerly Known As
Accera
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11101 West 120th Avenue
  • Suite 230
  • Broomfield, CO 80021
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 11101 West 120th Avenue
  • Suite 230
  • Broomfield, CO 80021
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerecin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 17-Jun-2024 $3.74M Completed Clinical Trials - Phase 3
13. Later Stage VC (Series B2) 02-Aug-2022 Completed Clinical Trials - Phase 2
12. Later Stage VC (Series A2) 14-Sep-2021 Completed Clinical Trials - Phase 2
11. Secondary Transaction - Private 01-Jun-2021 Completed Clinical Trials - Phase 1
10. Later Stage VC (Series 2) 01-Feb-2021 Completed Clinical Trials - Phase 1
9. Later Stage VC 05-Oct-2018 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series F) 26-Mar-2018 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series E) 21-Jan-2014 Completed Clinical Trials - Phase 1
6. Debt - General 24-May-2012 $8.78M $81.2M Completed Clinical Trials - Phase 1
5. Later Stage VC (Series C1) 21-Dec-2010 $11M $72.4M Completed Clinical Trials - Phase 1
To view Cerecin’s complete valuation and funding history, request access »

Cerecin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series A2
Series 2
Series 1 11,983,134 $0.001000 8% $2.93 $2.93 1x $2.93 10.49%
Junior Pref 44,780,778 $0.001000 8% $2.93 $2.93 1x $2.93 39.2%
To view Cerecin’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cerecin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutics technology designed to treat memory impairment and other neurodegenerative diseases. The compa
Drug Discovery
Broomfield, CO
35 As of 2026

Singapore, Singapore
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cerecin Competitors (30)

One of Cerecin’s 30 competitors is Hummingbird Bioscience, a Venture Capital-Backed company based in Singapore, Singapore.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hummingbird Bioscience Venture Capital-Backed Singapore, Singapore
Verge Labs Venture Capital-Backed San Francisco, CA
TauRx Pharmaceuticals Private Equity-Backed Aberdeen, United Kingdom
Alzheon Venture Capital-Backed Framingham, MA
Q Therapeutics Venture Capital-Backed Salt Lake City, UT
You’re viewing 5 of 30 competitors. Get the full list »

Cerecin Patents

Cerecin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024384650-A1 Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same Pending 26-Nov-2023
EP-4812156-A1 Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same Pending 26-Nov-2023
WO-2025109567-A1 Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same Inactive 26-Nov-2023
AU-2024284207-A1 Compositions of and methods of making ultra-pure tricaprilin Pending 09-Jun-2023
EP-4724415-A1 Compositions of and methods of making ultra-pure tricaprilin Pending 09-Jun-2023 A61P19/02
To view Cerecin’s complete patent history, request access »

Cerecin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerecin Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
AFW Partners Venture Capital Minority
Arche Investment Corporate Venture Capital Minority
Cheongdam Investment PE/Buyout
Hana Financial Group Holding Company Minority
IBK Capital Investment Bank Minority
You’re viewing 5 of 13 investors. Get the full list »

Cerecin FAQs

  • When was Cerecin founded?

    Cerecin was founded in 2000.

  • Where is Cerecin headquartered?

    Cerecin is headquartered in Broomfield, CO.

  • What is the size of Cerecin?

    Cerecin has 35 total employees.

  • What industry is Cerecin in?

    Cerecin’s primary industry is Drug Discovery.

  • Is Cerecin a private or public company?

    Cerecin is a Private company.

  • What is Cerecin’s current revenue?

    The current revenue for Cerecin is .

  • How much funding has Cerecin raised over time?

    Cerecin has raised $317M.

  • Who are Cerecin’s investors?

    AFW Partners, Arche Investment, Cheongdam Investment, Hana Financial Group, and IBK Capital are 5 of 13 investors who have invested in Cerecin.

  • Who are Cerecin’s competitors?

    Hummingbird Bioscience, Verge Labs, TauRx Pharmaceuticals, Alzheon, and Q Therapeutics are some of the 30 competitors of Cerecin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process